Investors Aren't Impressed as Charlie Sheen Reveals He Wants in on Tiny CytoDyn's HIV Drug Trial

It’s not every day you see the CEO of a publicly held biotech company on a daytime talk show with a major celebrity who wants in on a clinical trial, but that’s just what happened on the Dr. Oz show yesterday. Actor Charlie Sheen, who has been documenting his fight against HIV on the show, admitted he made a mistake pursuing an alternative goat-milk based treatment in Mexico and said he would like instead to enroll in a clinical trial of an injectable treatment being developed by CytoDyn, a tiny Vancouver company that trades over-the-counter.

The company’s CEO, Nader Pourhassan, sat next to Sheen on the soundstage and said that if the actor qualifies he’ll be welcome into the trial.